|
Good-Life-Science-Practices, Validation and Risk-Assessment
Our presentation (lecture) will show special requirements located to pharmaceutical
(process-) documentation, like these take place e.g. in context of GxP validation
(good life science practices). Official examinations, the clear context of pharmaceutical
work flow, production and logistic-alter-natives will be the main focus of all (FDA-)
Inspections.
In-plant processes will be brought together e.g. in accordance with the Businesses Process Modeling notation (BPMN, holistic open standard for the modeling, implementation and execution of business processes) into comprehensive reports. The admission of the business processes takes place gradually or stepwise, according to responsibilities or to refer field-activity. All individual elements are assigned by applicable documents. The depth of the documentation takes place in relation to the risk-assessment-analyses. |
![]() |
|||||
|
from office binder ... |
||||||
![]() |
||||||
|
to HTML-Documents! |
||||||
![]() |
||||||
|
|
|
This
lecture (see
here
or
print-version ) had been part of |
||||
|
© 2006-11-01 (vW) |
November 2 – 11, 2006 in University of Damascus, Homs, Aleppo (Syrian) |
|||||